Y-a-t-il eu un ajustement sur les % de décès des différents bras de Solidarity où est-ce une erreur? Tous les résultats diffèrent de ce que je trouve. 1ère Image les résultats affichés dans l'essai, 2ème image mes résultats. https://t.co/dGoNEmhTVR https:/
@caffepreto @Zornek1 @DomDasThreads @jairbolsonaro Esse artigo aí é de Maio e alguns parágrafos depois são admitas as limitações do estudo, como idade e dados incompletos. Esse outro artigo aqui é mais recente (semana passada) e tem uma amostra maior. comp
RT @MIKITO_777: レムデシビル、ヒドロキシクロロキン、ロピナビル、インターフェロン等、新型コロナの治療薬として期待された薬剤の大規模治験の結果が発表されました。 残念ながら死亡率を有意に改善させた薬剤はありませんでした。 今のところ明らかに死亡率を明らかに改善す…
RT @Rumindahg: #remdesivir does not help hospitalized patients or shorten recovery time in #Covid_19 @WHO #Solidarity trial 11,330 patient…
RT @AndreasLaupacis: Good news: high quality science about #COVID__19 from @WHO. Bad news: none of remdesivir, hydroxychloroquine, lopinavi…
RT @MartinLandray: Results of the @WHO SOLIDARITY trial: 4 drugs tested in 11,266 patients with COVID in 405 hospitals in 30 countries: -…
RT @MartinLandray: Results of the @WHO SOLIDARITY trial: 4 drugs tested in 11,266 patients with COVID in 405 hospitals in 30 countries: -…
RT @influenzer3: ●Remdesivirに死亡率減少効果は全くない →WHO主導の国際臨床試験、Solidarity Therapeutics Trialの結果です。 Remdesivir、HCQ、LPV/r、Interferon-β1aの4つとも死亡率改善効果…
RT @serapsimsekyvz: COVID-19 için yeniden konumlandırılarak tüm dünyada kullanılan antiviraller başarılı olamadı:(( Yeni, özgül antiviralle…
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results https://t.co/8u49ziHR8Q
No i się zesrało: https://t.co/sWyxzGY5Re "These Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens appeared to have little or no effect on hospitalized COVID -19, as indicated by overall mortality, initiation of ventilation and duration
Is #Remdesivir the new #HydroxyChloroquine? little or no effect on hospitalized COVID-19 on overall mortality, initiation of ventilation and duration of hospital stay... waiting to be peer reviewed... https://t.co/Y2qO4flgUR
RT @ygjumi: Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results https://t.co/b5ZPEGYAI3
RT @GreggWStone: Pre-print of WHO SOLIDARITY RCT: Remdesivir, Hydroxychloroquine, Lopinavir and Interferon in 11,266 hosp'd pts with COVID…
RT @DrEricDing: 2) and they indeed checked subgroups. and did a meta analysis pooling. Still nothing burger 🍔 for remdesivir. https://t.co/…
RT FranciscoMarty_ https://t.co/aVVo4sHMg5 "I have read the #solidarityTrial preprint: https://t.co/4ugGoWj7K1 Its supplementary material:https://t.co/mx1ZLYR3Zy its posted protocol: https://t.co/ABICWe0PP0 The CRF: https://t.co/gGQuKxYSMM Th
I have read the #solidarityTrial preprint: https://t.co/jaFlmhflxx Its supplementary material:https://t.co/EJhxScWPHl its posted protocol: https://t.co/FaKnOB9jUr The CRF: https://t.co/74OSRCuSLK The final report from #ACTT1 for contrast: https://t.co/
RT @ABsteward: 🔥Breaking news🔥 #SOLIDARITY @WHO 405 hospitals, 30 countries, n=11k Interim results indicate Rremdesivir,HCQ,lopinavir/riton…
Probably next example that HTA/EBM is just disregarded during the pandemic. 'Remdesivir, HCQ, Lopinavir & IFN regimens appeared to have little or no effect on hospitalized COVID-19'. Looking forward to the publication (w/o sponsorship publication bias?
RT @influenzer3: ●Remdesivirに死亡率減少効果は全くない →WHO主導の国際臨床試験、Solidarity Therapeutics Trialの結果です。 Remdesivir、HCQ、LPV/r、Interferon-β1aの4つとも死亡率改善効果…
RT @EricTopol: The SOLIDARITY randomized trial of 4 repurposed drugs in 11, 266 hospitalized patients with #COVID19: HCQ, Remdesivir, Inter…
RT @IshanAdhikarii: २०- सरल नेपाली भाषामा कसरी बुझाउने ? के Remdesvir को पछाड़ी हाम्रो दाजु भाईहरु दौडिनु को कुनै औचित्य अझै बाँकी छ भनेर…
२०- सरल नेपाली भाषामा कसरी बुझाउने ? के Remdesvir को पछाड़ी हाम्रो दाजु भाईहरु दौडिनु को कुनै औचित्य अझै बाँकी छ भनेर ? @KiranRP @mykrob @sudeepkhaniya https://t.co/lsWCqM0HH5
RT @ygjumi: Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results https://t.co/b5ZPEGYAI3
RT @KariTikkinen: WHO #SOLIDARITYtrial results recently posted on MedRxiv at https://t.co/PBP5qFEUvk This reports provides @WHO SOLIDARITY…
Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results https://t.co/b5ZPEGYAI3
RT @EMSwami: WHO SOLIDARITY Study: Remdesivir showed no mortality benefit in comparison to control https://t.co/TaGFDQaeGZ 2750 got remdes…
"little to no benefit..." #Covid_19 @WHO #NowWhat? #Remdesivir Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results https://t.co/Rzd2h4KB18
RT @EricTopol: The SOLIDARITY randomized trial of 4 repurposed drugs in 11, 266 hospitalized patients with #COVID19: HCQ, Remdesivir, Inter…
RT @EARL_Med_Tw: レムデシビル,ヒドロキシクロロキン,ロピナビル/リトナビル(カレトラ®︎),インターフェロンは,入院を要する新型コロナウイルス感染症患者において効果はわずか,もしくはほぼなしであった.30ヵ国405施設11266例RCT(プレプリント論文 20…
Inutilidad de cloroquina, hidroxicloroquina, remdesivir, lopinavir y ritonavir e interferón. ¿Cuántos pacientes muertos por su uso innecesario? https://t.co/hh8Kc2g3pL Lo saben los prescriptores? Y los protocoleros? Lo saben!!!
"No study drug definitely reduced mortality (in unventilated patients or any other subgroup of entry characteristics). #Remdesivir #Hydroxychloroquine #Lopinavir and #Interferon regimens appeared to have little or no effect on hospitalized COVID-19" https
RT @MartinLandray: Results of the @WHO SOLIDARITY trial: 4 drugs tested in 11,266 patients with COVID in 405 hospitals in 30 countries: -…
Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results | medRxiv https://t.co/u06TSc15sq
RT @JeremyFarrar: Not the result anyone hoped for. But so important to have robust, definitive data from large randomised trials. Huge cre…
RT @GreggWStone: Pre-print of WHO SOLIDARITY RCT: Remdesivir, Hydroxychloroquine, Lopinavir and Interferon in 11,266 hosp'd pts with COVID…
RT @MartinLandray: Results of the @WHO SOLIDARITY trial: 4 drugs tested in 11,266 patients with COVID in 405 hospitals in 30 countries: -…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @serapsimsekyvz: COVID-19 için yeniden konumlandırılarak tüm dünyada kullanılan antiviraller başarılı olamadı:(( Yeni, özgül antiviralle…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @SouthAfricanASP: #Dexamethasone & equivalent steroids. remain the only therapeutic to reduce mortality from #COVID19 as @WHO SOLIDARI…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @EricTopol: The SOLIDARITY randomized trial of 4 repurposed drugs in 11, 266 hospitalized patients with #COVID19: HCQ, Remdesivir, Inter…
@Calimer30438496 @Assita_Kanko efficiënte behandeling? Welke? https://t.co/JOaR0l0gdc
Per tutti quelli che…ormai ci sono le cure Ecco il preprint del WHO https://t.co/XP0ITDKmEw Io metto le figurine, noi mettiamo le mascherine stiamo lontani ci laviamo le mani. E per quelli che…siamo stati bravi, il prossimo anno ci baceremo, ci ammucchiere
RT @aminamnzr: Just därför måste vi göra randomiserade studier även under en pandemi. https://t.co/sCJd7CS1vo
RT @EARL_Med_Tw: レムデシビル,ヒドロキシクロロキン,ロピナビル/リトナビル(カレトラ®︎),インターフェロンは,入院を要する新型コロナウイルス感染症患者において効果はわずか,もしくはほぼなしであった.30ヵ国405施設11266例RCT(プレプリント論文 20…
Please, if I have to get admitted with #COVID, DO NOT give me any of the above (or below)
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @EricTopol: The SOLIDARITY randomized trial of 4 repurposed drugs in 11, 266 hospitalized patients with #COVID19: HCQ, Remdesivir, Inter…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @DrSandeepRai2: Repurposed antivirals for COVID-19 disappoint in WHO’s SOLIDARITY trial https://t.co/U8L9wbJcnV https://t.co/9GrRyXc761
RT @GermHunterMD: Solidarity preliminary report now published (as pre-print) Clearly zero overall 28 d mortality benefit to remdesivir “T…
RT @AlvarezMorenoC: Primeros resultados del estudio Solidaridad. El primer análisis con 11.000 pacientes. Infortunadamente ninguno de los…
RT @SouthAfricanASP: #Dexamethasone & equivalent steroids. remain the only therapeutic to reduce mortality from #COVID19 as @WHO SOLIDARI…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…
RT @DrSandeepRai2: Repurposed antivirals for COVID-19 disappoint in WHO’s SOLIDARITY trial https://t.co/U8L9wbJcnV https://t.co/9GrRyXc761
RT @VinGuptaMD: The data on Remdesivir was never convincing. Yesterday’s large study only confirms that. At least $70 million in American…
RT @GermHunterMD: Solidarity preliminary report now published (as pre-print) Clearly zero overall 28 d mortality benefit to remdesivir “T…
@Parsahaidariza2 بنظر Remdesivir و.. دارو هایی نیستند که قاعده بازی رو عوض کنه فعلا تنها درمان مجود همون حمایتی هست، با این اوصاف دو فرضیه محتمل هست،اول امار مبتلایان در حد اکثر اشباع هست یعنی احتمالا خیلی بیشتر مبتلا شدند، دوم کمبود زیر ساخت پزشکی برای د
RT @EARL_Med_Tw: レムデシビル,ヒドロキシクロロキン,ロピナビル/リトナビル(カレトラ®︎),インターフェロンは,入院を要する新型コロナウイルス感染症患者において効果はわずか,もしくはほぼなしであった.30ヵ国405施設11266例RCT(プレプリント論文 20…
RT @GermHunterMD: Solidarity preliminary report now published (as pre-print) Clearly zero overall 28 d mortality benefit to remdesivir “T…
RT @BulentTutluoglu: Remdesivirîn yanısıra Lopinavir/ritonavir,Hidroksiklorokin ve interferonun da ölüm oranlarını azaltmada etkisi yok . Ü…
RT @EARL_Med_Tw: レムデシビル,ヒドロキシクロロキン,ロピナビル/リトナビル(カレトラ®︎),インターフェロンは,入院を要する新型コロナウイルス感染症患者において効果はわずか,もしくはほぼなしであった.30ヵ国405施設11266例RCT(プレプリント論文 20…
RT @JeremyFarrar: Not the result anyone hoped for. But so important to have robust, definitive data from large randomised trials. Huge cre…
RT @JuanGrvas: Lo sabíamos. Oct 15 2020. Arrogancia médica sobre torres de ignorancia. Tratamiento de #covid19: inutilidad de cloroquina, h…
RT @bacigalupe: Repurposed antiviral drugs for COVID-19 trial results: Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens ap…
RT @bacigalupe: Repurposed antiviral drugs for COVID-19 trial results: Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens ap…
RT @bacigalupe: Repurposed antiviral drugs for COVID-19 trial results: Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens ap…
Repurposed antiviral drugs for COVID-19 trial results: Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens appeared to have little or no effect on hospitalized COVID-19. https://t.co/a9kx5YfREm
Looking forward to this! #COVID19 #Remdesivir
RT @rafa_romaguera: Bombazo 😔. Ninguno de los farmacos estudiados tiene efecto en la mortalidad por #COVID19
@VP @Mike_Pence
RT @WmHaseltine: This meta analysis of the effectiveness of a set of widely used antiviral drugs to treat Covid-19 reveals no effect on du…
This meta analysis of the effectiveness of a set of widely used antiviral drugs to treat Covid-19 reveals no effect on duration of illness or mortality. Gilead, the company promoting remdesivir disputes the findings based on their own trial results. http
Repurposed antivirals for COVID-19 disappoint in WHO’s SOLIDARITY trial https://t.co/U8L9wbJcnV https://t.co/9GrRyXc761
RT @glbryson: SOLIDARITY trial results are out and summarized below. Amazing work by @WHO. Preprint available @medrxivpreprint at https://…
RT @doctimcook: SOLIDARITY is not a 'negative trial' RCT: 11,266 patients, 405 hospitals, 30 countries Clarifying which drugs (many expens…
Repurposed antivirals for COVID-19 disappoint in WHO’s SOLIDARITY trial https://t.co/A3FSWdAGrj Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/B2i3IORqSn
RT @rafa_romaguera: Bombazo 😔. Ninguno de los farmacos estudiados tiene efecto en la mortalidad por #COVID19
SOLIDARITY trial, the largest antiviral study thus far in hospitalized patients. overall death rate 12%. remdesivir shows no mortality benefit, hydroxycholorquine and interferon trend to harm. overall continues to support remdesivir should be used early.
Summary (https://t.co/quJpw1DD7i) and original paper (https://t.co/6xGZKMUv32) on new, larger study on #COVID19 therapies. #medtwitter #research
The paper “Repurposed antiviral drugs for COVID-19; interim W...” (https://t.co/AZavF0Pqbd) has been reviewed by a set of automated tools; find the results of the analysis here: https://t.co/aBxl61zbTN. We detected 2 of 5 rigor criteria and 0 key resources
RT @MathieuMolimard: Comme prévu : aucun antiviral n'est efficace dans la #COVID19 Prépublication de solidarity/discovery https://t.co/fhG…
Bummer! In this huge 30 country, 11k patient RCT - Remdesivir, Hydroxychloroquine, Lopinavir & Interferon regimens appeared to have little or no effect on hospitalized #COVID19 patients. Forthcoming in #NEJM. #AcademicTwitter #MedTwitter https://t.co/
RT @ABsteward: 🔥Breaking news🔥 #SOLIDARITY @WHO 405 hospitals, 30 countries, n=11k Interim results indicate Rremdesivir,HCQ,lopinavir/riton…